![conference banner](/images/conference-banner.jpeg)
Abstract
Carotenoids have been proposed to exert beneficial effects in several chronic diseases, including cancer and cardiovascular diseases. Many of the biological actions of carotenoids have been attributed to their antioxidant properties, through the antioxidant capacity of the carotenoid molecule per se or through their possible influences on intracellular redox status. However, the exact mechanism by which carotenoids exert their beneficial effects are still under debate. Increasing evidence shows that carotenoids, and their metabolites, may modulate molecular pathways involved in cell proliferation, acting at Akt, tyrosine kinases, mitogen activated protein kinase (MAP kinase) and growth factor signaling cascades. Moreover, there is now strong evidence for an involvement of carotenoids in the regulation of apoptosis through modulatory effects on the activation of caspase cascade and on the expression of Bcl-2 family proteins and transcription factors. Inhibitory or stimulatory actions at these pathways are likely to affect cellular functions by altering the phosphorylation state of target molecules and by modulating gene expression. A clear understanding of the mechanisms of action of carotenoids, either as redox agents or modulators of cell signaling and the influence of their metabolism on these properties is key to the evaluation of these biomolecules as anticancer and cardioprotective agents.
Keywords: Carotenoids, signal transduction, cancer, inflammation, cardiovascular diseases
Current Signal Transduction Therapy
Title: Carotenoids as Modulators of Intracellular Signaling Pathways
Volume: 1 Issue: 3
Author(s): Paola Palozza, Simona Serini and Gabriella Calviello
Affiliation:
Keywords: Carotenoids, signal transduction, cancer, inflammation, cardiovascular diseases
Abstract: Carotenoids have been proposed to exert beneficial effects in several chronic diseases, including cancer and cardiovascular diseases. Many of the biological actions of carotenoids have been attributed to their antioxidant properties, through the antioxidant capacity of the carotenoid molecule per se or through their possible influences on intracellular redox status. However, the exact mechanism by which carotenoids exert their beneficial effects are still under debate. Increasing evidence shows that carotenoids, and their metabolites, may modulate molecular pathways involved in cell proliferation, acting at Akt, tyrosine kinases, mitogen activated protein kinase (MAP kinase) and growth factor signaling cascades. Moreover, there is now strong evidence for an involvement of carotenoids in the regulation of apoptosis through modulatory effects on the activation of caspase cascade and on the expression of Bcl-2 family proteins and transcription factors. Inhibitory or stimulatory actions at these pathways are likely to affect cellular functions by altering the phosphorylation state of target molecules and by modulating gene expression. A clear understanding of the mechanisms of action of carotenoids, either as redox agents or modulators of cell signaling and the influence of their metabolism on these properties is key to the evaluation of these biomolecules as anticancer and cardioprotective agents.
Export Options
About this article
Cite this article as:
Palozza Paola, Serini Simona and Calviello Gabriella, Carotenoids as Modulators of Intracellular Signaling Pathways, Current Signal Transduction Therapy 2006; 1 (3) . https://dx.doi.org/10.2174/157436206778226950
DOI https://dx.doi.org/10.2174/157436206778226950 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
![Wayfinder Image](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
A Pan-Cancer Review of <i>ALK</i> Mutations: Implications for Carcinogenesis and Therapy
Current Cancer Drug Targets Synthesis and Biological Evaluation of the Salicylamide and Salicylic Acid Derivatives as Anti-Estrogen Agents
Medicinal Chemistry Is the Use of Autologous Platelet-Rich Plasma Gels in Gynecologic, Cardiac, and General, Reconstructive Surgery Beneficial?
Current Pharmaceutical Biotechnology Update on the Rheumatologic Manifestations of Malignancy
Current Cancer Therapy Reviews Mast Cells and Basophils: Trojan Horses of Conventional Lin- Stem/Progenitor Cell Isolates
Current Pharmaceutical Design Chemoprevention Strategies for High Risk Women
Current Women`s Health Reviews Mutations of Chromatin Structure Regulating Genes in Human Malignancies
Current Protein & Peptide Science The Glycogen Synthase Kinase-3 in the Regulation of Ion Channels and Cellular Carriers
Current Medicinal Chemistry Influence of Tumor Microenvironment on the Distribution and Elimination of Nano-formulations
Current Drug Metabolism Editorial [Hot topic: Transportalopathy and Vascular Cell Dysfunction (Guest Editor: Luis Sobrevia)]
Current Vascular Pharmacology Radioprotective Effect of Febuxostat Against Testicular Damage Induced by Ionizing Radiation in Mice
Current Radiopharmaceuticals Glycosidated Phospholipids – a Promising Group of Anti-Tumour Lipids
Anti-Cancer Agents in Medicinal Chemistry Intraperitoneal Oncolytic and Tumor Vaccination Therapy with Replication-Competent Recombinant Virus: The Herpes Paradigm
Current Gene Therapy Metformin as a Radiation Modifier; Implications to Normal Tissue Protection and Tumor Sensitization
Current Clinical Pharmacology Tumor Angiogenesis and VEGFR-2: Mechanism, Pathways and Current Biological Therapeutic Interventions
Current Drug Metabolism Lynch Syndrome: Awareness among Medical Students at a United States Medical School
Current Women`s Health Reviews Signal Transduction Inhibitors in the Treatment of Breast Cancer
Current Medicinal Chemistry - Anti-Cancer Agents Extrapituitary Actions of GnRH Antagonists: Prospects for in vitro Fertilization Programs
Current Pharmaceutical Design A Focus on Microfluidics and Nanotechnology Approaches for the Ultra Sensitive Detection of MicroRNA
MicroRNA Trabectedin (Yondelis®) as a Therapeutic Option in Gynecological Cancers: A Focus on its Mechanisms of Action, Clinical Activity and Genomic Predictors of Drug Response
Current Drug Targets